MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jjco/hyaf021

Медицинская библиотека · Japanese journal of clinical oncology · 2026

Trends in net survival for prostate cancer in Japan, 2000-14 (CONCORD-3).

Tanaka Rina, Matz Melissa, Sugiyama Hiromi, Oki Izumi, Shibata Akiko, Nakata Kayo, Kajiwara Saito Mari, Matsuzaka Masashi, Nishio Marisa, Oze Isao, Watanabe Kaname, Gatellier Laureline, Yoshida Isao, Ito Hidemi, Teramoto Norihiro, Yamashita Natsumi, Kaizaki Yasuharu, Moki Fumitaka, Kurosawa Katsuki, Nemoto Yuji, Narimatsu Hiroto, Kanemura Seiki, Miyashiro Isao, Mori Daisuke, Fujita Shin, Matsuda Tomohiro, Coleman Michel P, Allemani Claudia, Di Carlo Veronica

СтатьяПеревод в очереди

Аннотация

BACKGROUND

We aimed at assessing 15-year trends in 5-year net survival for men diagnosed with prostate cancer during 2000-2014 and registered by 16 Japanese regional population-based cancer registries included in the CONCORD-3 study.

METHODS

We included data on adult men (15-99 years) diagnosed with prostate cancer during 2000-2014 and followed-up to 31 December 2014. We grouped patients into five age groups (15-54, 55-64, 65-74, 75-84, and 85-99 years) and four morphology groups according to the ICD-O-3 classification (epithelial, neuroendocrine, other specified morphologies, and malignant neoplasm, not otherwise specified). We grouped patients by stage at diagnosis into localized, regional, and advanced disease. We estimated 5-year net survival by age group, morphological subtype and stage using the Pohar Perme estimator, correcting for background mortality. All-ages estimates were standardized with the International Cancer Survival Standard weights.

RESULTS

Age-standardized 5-year net survival increased over time, from 85.9% in 2000-2004 to 93.0% in 2010-2014. Survival was higher than 90% for epithelial tumors, and for localized and regional disease. Five-year net survival for patients with distant metastasis was poor at 47.3% (95% CI. 39.4-55.1%) during 2010-2014.

CONCLUSIONS

The improvement in survival for prostate cancer may be due to the high and increasing proportion of patients with localized disease and with epithelial tumors, for which 5-year survival approaches 100%. A comprehensive analysis of long-term survival over a longer period of time would be essential to investigate further the factors contributing to the increasing trend in survival.

Для цитирования: Tanaka Rina, Matz Melissa, Sugiyama Hiromi, Oki Izumi, Shibata Akiko, Nakata Kayo, Kajiwara Saito Mari, Matsuzaka Masashi, Nishio Marisa, Oze Isao, Watanabe Kaname, Gatellier Laureline, Yoshida Isao, Ito Hidemi, Teramoto Norihiro, Yamashita Natsumi, Kaizaki Yasuharu, Moki Fumitaka, Kurosawa Katsuki, Nemoto Yuji, Narimatsu Hiroto, Kanemura Seiki, Miyashiro Isao, Mori Daisuke, Fujita Shin, Matsuda Tomohiro, Coleman Michel P, Allemani Claudia, Di Carlo Veronica. Trends in net survival for prostate cancer in Japan, 2000-14 (CONCORD-3).. Japanese journal of clinical oncology. 2026. DOI: 10.1093/jjco/hyaf021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.